Medical News

RSS

New chemotherapeutic agents for colorectal cancer: High-cost/low-value medical care

New chemotherapy agents appear associated with improvements in survival time for patients with metastastic colorectal cancer, but at substantial cost, according to a report in the March 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

18 Mar 2010

Poll: Use of booster seats drops sharply to 40% by age 8

All 50 states have some type of child safety seat law, 28 of which require kids to use child safety seats or booster seats through age 8 to reduce the risk of injuries in car crashes. But the latest C.S. Mott Children's Hospital National Poll on Children's Health finds that while nearly all parents report their kids, ages 5 and younger, use booster seats or car seats while riding in vehicles, use of booster seats drops sharply to 40 percent by age 8.

18 Mar 2010

Bavarian Nordic completes last step to support use of IMVAMUNE, receives FDA notification

Bavarian Nordic A/S announced today that it has received notification that the U.S. Food and Drug Administration (FDA) has accepted all the actions taken by the company to address the observations made during the inspection of the manufacturing facilities in 2009. This was the last step along with the clinical and preclinical data that will be used to potentially support the use of IMVAMUNE® following a declared emergency.

18 Mar 2010

Researchers find retinoic acid regulates SHF tissue formation

Researchers at the Keck School of Medicine of the University of Southern California have identified a key cellular mechanism that guides embryonic heart tissue formation-a process which, if disrupted, can lead to a number of common congenital heart defects.

18 Mar 2010

SEIU's civil lawsuit against former local union staff and elected leaders: Trial set for Monday

For the last year, SEIU officials have been suing 29 local union reformers and whistleblowers who exposed the union's corruption and backroom deals and helped healthcare workers protect their democratic right to join a new union after a hostile takeover.

18 Mar 2010

Evaluating all Medicare plan options can reduce healthcare costs

Nearly 8 million former workers have disabilities so severe that they rely on Social Security Disability Insurance benefits, and an estimated 3.3 million more will apply for disability benefits this year. For these people and others suffering from serious conditions and disabilities, taking the right steps quickly to manage costs is essential for their financial and health well-being, according to Allsup, a nationwide provider of Social Security disability representation and Medicare plan selection services.

18 Mar 2010

Genes allowing opium poppy to make codeine and morphine discovered

Researchers at the University of Calgary have discovered the unique genes that allow the opium poppy to make codeine and morphine, thus opening doors to alternate methods of producing these effective painkillers either by manufacturing them in a lab or controlling the production of these compounds in the plant.

18 Mar 2010

Societies endorse AIUM Training Guidelines for musculoskeletal ultrasound

The AIUM is pleased to announce that 4 professional societies have collaborated with AIUM to endorse the recent AIUM Training Guidelines for the Performance of Musculoskeletal Ultrasound Examinations. The guidelines allow for a several practitioners, including physicians, osteopathic physicians, podiatrists, and sonographers, to perform musculoskeletal ultrasound examinations, marking significant promise for the future of this growing field.

18 Mar 2010

Having lower TSH levels while taking thyroxine replacement is not detrimental to health, says study

New research shows that it may be safe for patients taking thyroxine replacement to have low but not suppressed thyroid stimulating hormone (TSH) levels. The research, presented at the Society for Endocrinology BES meeting in Manchester, shows for the first time that it may be safe for patients to take slightly higher doses of thyroxine than are currently recommended.

18 Mar 2010

Molecular basis of detecting tissue-damaging chemicals goes back more than 500 million years

Whenever you choke on acrid cigarette smoke, feel like you're burning up from a mouthful of wasabi-laced sushi, or cry while cutting raw onions and garlic, your response is being triggered by a primordial chemical sensor conserved across some 500 million years of animal evolution, report Brandeis University scientists in a study in Nature this week.

18 Mar 2010

EDP Biotech briefs Tennessee state legislators on ColoMarker colon cancer test

EDP Biotech, a Knoxville-based company today briefed Tennessee state legislators on its revolutionary ColoMarker™ colon cancer test which potentially could save 50,000 lives and more than $12 billion in healthcare costs annually in the U.S. Legislators were also provided the opportunity to personally experience the ColoMarker™ test by enrolling in the control study group for EDP’s latest research.

18 Mar 2010

NexACT technology demonstrates ability to deliver Taxol subcutaneously

NexMed, Inc., a specialty CRO and a developer of products based on the NexACT® technology, today announced that pre-clinical results from the research and development group at its Bio-Quant subsidiary have successfully demonstrated the ability of the NexACT technology to deliver insulin and other large molecule drugs such as Taxol subcutaneously, in a depot-like fashion (or slow release) over a 24 hour period from a single injection.

18 Mar 2010

Low vitamin D levels in African American children connected with high asthma rates

Researchers at Children's National Medical Center have discovered that African American children with asthma in metropolitan Washington, DC, are significantly more likely to have low levels of vitamin D than healthy African American children.

18 Mar 2010

Scientific revelations discovered during Retina Implant’s first human clinical trial

Retina Implant, AG, a leading developer of subretinal implants for the visually impaired, today announced scientific revelations discovered during the company’s first human clinical trial. The results achieved in the 11 patients that were involved in the trial exceeded the company’s expectations for their first trial.

18 Mar 2010

OriGene Technologies to build TrueMAB monoclonal antibody collection with $16M Series B financing funds

OriGene Technologies, Inc., a leading gene-centric life sciences company, announced the completion of a $16 million Series B financing led by IDG-Accel, SBI & TH Venture Capital Enterprise, and Zero2IPO. OriGene's previous investors Morningside Venture Investments and President International Development Corp. (PIDC) also participated in this round. The proceeds from the funding will be used to continue to build OriGene's TrueMAB™ monoclonal antibody collection.

18 Mar 2010

Combination of gemcitabine and cisplatin limits the progression of endometrial cancer: Study

Researchers from The University of Texas M. D. Anderson Cancer Center report that in a small study of women with advanced or recurrent endometrial cancer, gemcitabine and cisplatin, when used in combination, produced a response rate in fifty percent of patients.

18 Mar 2010

Research shows phenomenon of brain replay is much more complex

The hippocampus, a part of the brain essential for memory, has long been known to "replay" recently experienced events. Previously, replay was believed to be a simple process of reviewing recent experiences in order to help consolidate them into long-term memory.

18 Mar 2010

Prometheus Laboratories, Bayer Schering Pharma form research collaboration and license agreement

Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the execution of a research collaboration and license agreement with Bayer Schering Pharma AG, Germany, a worldwide leading specialty pharmaceutical company. The collaboration partners Prometheus' proprietary oncology diagnostic platform with Bayer's broad oncology pipeline in an effort to stratify patients to appropriate drug candidates and potentially accelerate the development of novel oncology therapeutic products.

18 Mar 2010

Medtronic's Advisa DR MRI SureScan pacemaker commercially available in selected European geographies

Medtronic, Inc. announced today the commercial availability of the Advisa DR MRI™ SureScan™ pacemaker in selected European geographies. The Advisa DR MRI SureScan pacemaker is the company’s second-generation pacemaker in a portfolio of devices from Medtronic designed, tested, and approved for use as labeled with MRI machines in selected European geographies.

18 Mar 2010

Expectant mothers’ spatial memory ability reduces during later stages of pregnancy

New research has found that pregnant women's ability to remember the position of objects previously seen is reduced as pregnancy progresses. These findings will be presented this week at the annual Society for Endocrinology BES conference in Manchester.

18 Mar 2010

Medical News

New chemotherapeutic agents for colorectal cancer: High-cost/low-value medical care

Poll: Use of booster seats drops sharply to 40% by age 8

Bavarian Nordic completes last step to support use of IMVAMUNE, receives FDA notification

Researchers find retinoic acid regulates SHF tissue formation

SEIU's civil lawsuit against former local union staff and elected leaders: Trial set for Monday

Evaluating all Medicare plan options can reduce healthcare costs

Genes allowing opium poppy to make codeine and morphine discovered

Societies endorse AIUM Training Guidelines for musculoskeletal ultrasound

Having lower TSH levels while taking thyroxine replacement is not detrimental to health, says study

Molecular basis of detecting tissue-damaging chemicals goes back more than 500 million years

EDP Biotech briefs Tennessee state legislators on ColoMarker colon cancer test

NexACT technology demonstrates ability to deliver Taxol subcutaneously

Low vitamin D levels in African American children connected with high asthma rates

Scientific revelations discovered during Retina Implant’s first human clinical trial

OriGene Technologies to build TrueMAB monoclonal antibody collection with $16M Series B financing funds

Combination of gemcitabine and cisplatin limits the progression of endometrial cancer: Study

Research shows phenomenon of brain replay is much more complex

Prometheus Laboratories, Bayer Schering Pharma form research collaboration and license agreement

Medtronic's Advisa DR MRI SureScan pacemaker commercially available in selected European geographies

Expectant mothers’ spatial memory ability reduces during later stages of pregnancy

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News